AU2001218866A1 - Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration - Google Patents
Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administrationInfo
- Publication number
- AU2001218866A1 AU2001218866A1 AU2001218866A AU1886601A AU2001218866A1 AU 2001218866 A1 AU2001218866 A1 AU 2001218866A1 AU 2001218866 A AU2001218866 A AU 2001218866A AU 1886601 A AU1886601 A AU 1886601A AU 2001218866 A1 AU2001218866 A1 AU 2001218866A1
- Authority
- AU
- Australia
- Prior art keywords
- waldeyer
- strengthening
- ring
- mucosa
- glucan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A product to be administered by nose for preventing inflammatory or hypertrophic forms and strengthening the immune action in the Waldeyer's ring and the oronasal mucosa consists of a physiological action with a high concentration in a polysaccharide such as glucan. In particular, two solutions having different concentrations have been specified, namely a first physiological solution with a glucan concentration equal to 0.25 % for cleaning the nasal fossae and with a preventive hydrating, reepithelializing capability of strengthening the immune action in the Waldeyer's ring and the oronasal mucosa, and a physiological solution with a glucan concentration equal to 2 % for hydrating and reepithelializing the nasal mucosa, capable of strengthening the immune response in the Waldeyer's ring duringthe acute phase of the inflammatory, hypertrophic forms of the same. Glucan is preferably used in the form beta -(1-3)-glucan.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2000/000479 WO2002041900A1 (en) | 2000-11-22 | 2000-11-22 | Preparation for strengthening the immune response in the waldeyer's ring and the oronasal mucosa by intranasal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001218866A1 true AU2001218866A1 (en) | 2002-06-03 |
Family
ID=11133585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001218866A Abandoned AU2001218866A1 (en) | 2000-11-22 | 2000-11-22 | Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1337260B1 (en) |
AT (1) | ATE290873T1 (en) |
AU (1) | AU2001218866A1 (en) |
DE (1) | DE60018812T2 (en) |
ES (1) | ES2237477T3 (en) |
PT (1) | PT1337260E (en) |
WO (1) | WO2002041900A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0225502D0 (en) * | 2002-11-01 | 2002-12-11 | Zoolife Internat Ltd | Therapeutic and prophylactic preparations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0045718A3 (en) * | 1980-07-25 | 1983-01-19 | Ciba-Geigy Ag | Nasal compositions and method of preparing them |
US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
US5519009A (en) * | 1993-10-01 | 1996-05-21 | Donzis; Byron A. | Solubilized yeast glucan |
FR2780285B1 (en) * | 1998-06-29 | 2001-10-05 | Goemar Lab Sa | USE OF ISOOSMOTIC SALINE SOLUTIONS, THEIR PREPARATION METHOD AND ANTI-INFLAMMATORY DRUGS BASED ON SUCH SOLUTIONS |
-
2000
- 2000-11-22 ES ES00981644T patent/ES2237477T3/en not_active Expired - Lifetime
- 2000-11-22 PT PT00981644T patent/PT1337260E/en unknown
- 2000-11-22 AU AU2001218866A patent/AU2001218866A1/en not_active Abandoned
- 2000-11-22 WO PCT/IT2000/000479 patent/WO2002041900A1/en active IP Right Grant
- 2000-11-22 DE DE60018812T patent/DE60018812T2/en not_active Expired - Lifetime
- 2000-11-22 EP EP00981644A patent/EP1337260B1/en not_active Expired - Lifetime
- 2000-11-22 AT AT00981644T patent/ATE290873T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1337260B1 (en) | 2005-03-16 |
EP1337260A1 (en) | 2003-08-27 |
PT1337260E (en) | 2005-05-31 |
ES2237477T3 (en) | 2005-08-01 |
DE60018812T2 (en) | 2005-08-11 |
WO2002041900A1 (en) | 2002-05-30 |
DE60018812D1 (en) | 2005-04-21 |
ATE290873T1 (en) | 2005-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX353044B (en) | Sustained release of antiinfectives. | |
AU690377B2 (en) | Application of superoxide dismutase in liposomes | |
EP1283054A4 (en) | Drugs for complications of diabetes and neuropathy and utilization thereof | |
ES2136883T3 (en) | NEW IMPROVED FORMULATION OF AMINOGLUCOSIDE FOR ADMINISTRATION IN THE FORM OF AEROSOL. | |
WO2003024387A3 (en) | Method and pharmaceutical composition for treating inflammation | |
DK1107732T3 (en) | Oral liquid mucoadhesive preparations | |
HUP0104702A2 (en) | Therapeutic agent for the suppression of snoring noises | |
NZ505919A (en) | Nasal solutions | |
CA2336945A1 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
EE03016B1 (en) | Oral Formulation for the Treatment of Central Dopamine Deficiency and Method for Its Preparation | |
CN115607464B (en) | Antibacterial stain-removing toothpaste and preparation method thereof | |
CA2507926A1 (en) | Pharmaceutical composition comprising chito-oligomers | |
CA2136404A1 (en) | Mucoadhesive, therapeutic or hygienic solid composition for application on oral or nasal mucosa | |
DE60116662D1 (en) | INHIBITION OF SYSTEMIC INFECTIONS IN PEOPLE AND SWIVELING WITH BALLASTS | |
JP2019182825A (en) | Ophthalmic composition | |
WO2002009679A3 (en) | Use of 13-cis retinoic acid for the treatment of emphysema | |
DE60208528D1 (en) | HIGHLY SULFATED DERIVATIVES OF K5 POLYSACCHARIDES AND THEIR PREPARATION | |
AU2001218866A1 (en) | Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration | |
IE891314L (en) | Pharmaceutical compositions of 1,5-d1¹(4-amidinophenoxy) pentane | |
SI0875248T1 (en) | Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid | |
CN110623848A (en) | Dentifrice with function of repairing oral mucosa and preparation method thereof | |
AU1665992A (en) | Novel taurine-based pharmaceutical composition for administration by inhalation | |
WO2004028457A3 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY | |
EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
ATE227555T1 (en) | LIQUID DENTAL CLEANERS |